CN114521654A - 一种激活细胞能量、修复受损器官组织细胞、强化干细胞治疗潜能的食疗组方 - Google Patents
一种激活细胞能量、修复受损器官组织细胞、强化干细胞治疗潜能的食疗组方 Download PDFInfo
- Publication number
- CN114521654A CN114521654A CN202210212245.5A CN202210212245A CN114521654A CN 114521654 A CN114521654 A CN 114521654A CN 202210212245 A CN202210212245 A CN 202210212245A CN 114521654 A CN114521654 A CN 114521654A
- Authority
- CN
- China
- Prior art keywords
- peptide
- bovine
- parts
- therapy formula
- dietary therapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 210000004027 cell Anatomy 0.000 title claims abstract description 48
- 238000002560 therapeutic procedure Methods 0.000 title claims abstract description 30
- 235000005911 diet Nutrition 0.000 title claims abstract description 21
- 230000000378 dietary effect Effects 0.000 title claims abstract description 20
- 230000003213 activating effect Effects 0.000 title claims abstract description 16
- 210000000056 organ Anatomy 0.000 title claims abstract description 16
- 238000005728 strengthening Methods 0.000 title claims abstract description 15
- 238000002660 stem cell treatment Methods 0.000 title description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 115
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 34
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims abstract description 33
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims abstract description 32
- 239000000843 powder Substances 0.000 claims abstract description 30
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 claims abstract description 17
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 17
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 claims abstract description 17
- 241000168517 Haematococcus lacustris Species 0.000 claims abstract description 17
- SQVRNKJHWKZAKO-PFQGKNLYSA-N N-acetyl-beta-neuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-PFQGKNLYSA-N 0.000 claims abstract description 17
- 108091005804 Peptidases Proteins 0.000 claims abstract description 17
- 239000004365 Protease Substances 0.000 claims abstract description 17
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims abstract description 17
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 17
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 claims abstract description 17
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims abstract description 17
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 17
- 239000011718 vitamin C Substances 0.000 claims abstract description 17
- 235000019766 L-Lysine Nutrition 0.000 claims abstract description 16
- 239000004472 Lysine Substances 0.000 claims abstract description 16
- 210000001519 tissue Anatomy 0.000 claims abstract description 15
- 210000000130 stem cell Anatomy 0.000 claims abstract description 12
- 235000013305 food Nutrition 0.000 claims abstract description 9
- 239000000203 mixture Substances 0.000 claims abstract description 7
- 241000283690 Bos taurus Species 0.000 claims description 101
- 101500013104 Pelophylax ridibundus Secretoneurin Proteins 0.000 claims description 17
- 210000003734 kidney Anatomy 0.000 claims description 17
- 210000004185 liver Anatomy 0.000 claims description 17
- 210000004072 lung Anatomy 0.000 claims description 17
- 210000000952 spleen Anatomy 0.000 claims description 17
- 239000002994 raw material Substances 0.000 claims description 16
- 230000001954 sterilising effect Effects 0.000 claims description 16
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 14
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 14
- 238000004659 sterilization and disinfection Methods 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 8
- 238000005303 weighing Methods 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 7
- 238000009472 formulation Methods 0.000 claims description 5
- 238000007599 discharging Methods 0.000 claims description 4
- 238000004806 packaging method and process Methods 0.000 claims description 4
- 230000001225 therapeutic effect Effects 0.000 claims description 2
- 230000036039 immunity Effects 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 7
- 230000009286 beneficial effect Effects 0.000 abstract description 5
- 102000008186 Collagen Human genes 0.000 abstract description 2
- 108010035532 Collagen Proteins 0.000 abstract description 2
- 235000013361 beverage Nutrition 0.000 abstract description 2
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 229920001436 collagen Polymers 0.000 abstract description 2
- 210000004177 elastic tissue Anatomy 0.000 abstract description 2
- 239000007787 solid Substances 0.000 abstract description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 2
- 230000008439 repair process Effects 0.000 description 9
- 206010028980 Neoplasm Diseases 0.000 description 6
- 230000006870 function Effects 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 235000013793 astaxanthin Nutrition 0.000 description 3
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 3
- 229940022405 astaxanthin Drugs 0.000 description 3
- 239000001168 astaxanthin Substances 0.000 description 3
- 210000004877 mucosa Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 229940045997 vitamin a Drugs 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000032677 cell aging Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 230000003405 preventing effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 208000031229 Cardiomyopathies Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 235000021336 beef liver Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000014461 bone development Effects 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229940108928 copper Drugs 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 235000005686 eating Nutrition 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 230000007368 endocrine function Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000004377 improving vision Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000036473 myasthenia Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011946 reduction process Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 235000011649 selenium Nutrition 0.000 description 1
- 229940091258 selenium supplement Drugs 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 235000016804 zinc Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明公开了一种激活细胞能量、修复受损器官组织细胞、强化干细胞治疗潜能的食疗组方，所述食疗组方包括：D‑核糖、磷脂酰丝氨酸、N‑乙酰神经氨酸、Y‑氨基丁酸、蛋白酶、雨生红球藻、维生素C、L‑赖氨酸、肽粉；本发明制备成食疗组方，该食疗组方为粉剂状的固体饮料，便于用户冲服；并且该食疗组方可以增强肌体免疫力，更有利于修复受损细胞，修复受损细胞的组合物促进胶原蛋白弹性纤维的形成，增强肌体免疫力，从而达到激活细胞能量、修复受损器官组织细胞、强化干细胞的功效，该食疗组方功能多样，能够科学平衡的对受损细胞进行修复，提高了受损细胞修复的效果。
Description
技术领域
本发明涉及修复细胞技术领域，具体为一种激活细胞能量、修复受损器官组织细胞、强化干细胞治疗潜能的食疗组方。
背景技术
衰老是所有生物体都要面对的问题，细胞衰老是生命的一部分，这个过程不可逆转，但越来越多的研究在把衰老的过程延缓和变长，治愈细胞抗衰老最根本的途径是修复细胞。
只有及时对受损细胞进行有效治疗，才从真正意义上保持年轻态；目前市场上修复细胞使用抗生素或激素，如果使用过量，对人体造成危害，并且大部分修复细胞使用抗生素或激素功能比较单一，无法科学平衡的对受损细胞进行修复，影响了受损细胞修复的效果。
发明内容
本发明的目的在于提供一种激活细胞能量、修复受损器官组织细胞、强化干细胞治疗潜能的食疗组方，以解决目前市场上修复细胞使用抗生素或激素，如果使用过量，对人体造成危害，并且大部分修复细胞使用抗生素或激素功能比较单一的问题。
为实现上述目的，本发明提供如下技术方案：一种激活细胞能量、修复受损器官组织细胞、强化干细胞治疗潜能的食疗组方，所述食疗组方包括：D-核糖、磷脂酰丝氨酸、N-乙酰神经氨酸、Y-氨基丁酸、蛋白酶、雨生红球藻、维生素C、L-赖氨酸、肽粉。
其中，所述食疗组方的各成分重量配比为：D-核糖15-20份、磷脂酰丝氨酸5-10份、N-乙酰神经氨酸5-10份、Y-氨基丁酸5-10份、蛋白酶1-3份、雨生红球藻15-20份、维生素C1-3份、L-赖氨酸5-10份、肽粉12-18份。
其中，所述肽粉包括：牛心肽、牛肺肽、牛肝肽、牛脾肽、牛肾肽、牛脑肽。
其中，所述肽粉的各成分重量配比为：牛心肽2-3份、牛肺肽2-3份、牛肝肽2-3份、牛脾肽2-3份、牛肾肽2-3份、牛脑肽2-3份。
其中，所述牛心肽、牛肺肽、牛肝肽、牛脾肽、牛肾肽和牛脑肽的重量比为：1:1:1:1:1:1。
其中，D-核糖具有扩张血管，增加心肌收缩能力，恢复心肌细胞的正常功能。能有效的改善冠心病、心绞痛、心肌缺血、心律失常、心慌、胸闷、气短等症状，也能够提高人体的免疫力，调节内分泌功能。能缓解疲劳、肌肉酸痛、四肢无力、腰膝酸软的症状。D核糖是五碳单糖，是核糖核酸的重要组成物质。能促进骨骼的发育，有防止小儿佝偻病和骨质疏松的作用。
磷脂酰丝氨酸可以帮助修复大脑损伤，磷脂酰丝氨酸是脑部神经的主要成分之一，可营养和活化脑中各种酶的活性，能延缓神经递质的减少进程，有助于修复、更新大脑受损细胞和清除有害物质；
N-乙酰神经氨酸能够调节IgG的抗炎活性，从而达到提升免疫力的作用。影响着宝宝免疫的第一道防线(皮肤和粘膜的阻挡作用)，能够提高呼吸道粘膜层的抵御能力；
Y-氨基丁酸能够激发运动的潜能，可以促进睡眠、美容润肤、健脑益智、促进大脑的活化性、延缓衰老，预防老年痴呆；
蛋白酶可促进胃肠蠕动消化功能，改善身体不适症状；
雨生红球藻积累了大量的虾青素成分，可入药，在医药领域用途广泛。虾青素能够被人体快速吸收，可以保护眼部健康，还能抑制癌细胞的生长，有预防癌症的作用。虾青素可以预防人体的动脉硬化，能够预防心脑血管疾病，有益人体健康；
维生素C可以作为抗氧化剂，保护其他抗氧化剂，如维生素A、维生素E和不饱和脂肪酸，防止自由基对人体伤害；
L-赖氨酸能够促进人体的发育，增强免疫力并有提高中枢神经功能的作用；
牛心肽抑制癌细胞抵抗肿瘤的发生，在生活中各种各样的癌症肿瘤悄悄的潜伏在人们的身体当中，经常吃牛心可以使人的身体更健康；牛肺肽含有丰富的蛋白质、维生素A、维生素E以及锌、硒、铜、锰等矿物质形式与免疫机能有关的酵素，这些物质都能很好的提高人体的免疫力，增强抗病能力；牛肝肽具有养血滋阴，补肝明目的功效，适量食用可以用于治疗虚劳羸瘦、血虚萎黄、青盲雀目、惊痛等病症；牛脾肽促进脑组织神经元的生长，改善脑血流分布和脑代谢，常常用于治疗心肌病和脑部疾病；牛肾肽可以补充蛋白质、维生素A、铁等,对防治营养不良、提高视力,防止夜盲、促进骨骼成长、促进皮肤粘膜生长，使皮肤湿润、细嫩、牙齿坚固、缺铁性贫血等；牛脑肽可以缓解由于不良的生活以及饮食习惯引起的失眠多梦。
其中，所述肽粉的制备方法包括以下步骤：
步骤一，按重量分别称取牛心肽、牛肺肽、牛肝肽、牛脾肽、牛肾肽、牛脑肽；
步骤二，然后依次将称取后的牛心肽、牛肺肽、牛肝肽、牛脾肽、牛肾肽、牛脑肽加入到反应釜中，通过反应釜混合均匀，然后出料，得到该肽粉。
一种激活细胞能量、修复受损器官组织细胞、强化干细胞治疗潜能的食疗组方的制备方法，包括以下步骤：
S101、按重量份分别称取D-核糖、磷脂酰丝氨酸、N-乙酰神经氨酸、Y-氨基丁酸、蛋白酶、雨生红球藻、维生素C、L-赖氨酸、肽粉，以备后续使用；
S102、先将D-核糖、磷脂酰丝氨酸、N-乙酰神经氨酸、Y-氨基丁酸和L-赖氨酸依次加入到反应釜内，通过反应釜搅拌10-15分钟，混合均匀，得到初始原料；
S103、然后将蛋白酶、雨生红球藻、维生素C和肽粉加入到反应釜中，通过反应釜继续搅拌10-15分钟，混合均匀，得到最终原料；
S104、将混合后的原料放入杀菌箱内，通过杀菌箱对混合原料进行杀菌处理，待杀菌结束后，进行封装处理，从而得到粉剂状的食疗组方。
与现有技术相比，本发明的有益效果是：
本发明通过D-核糖、磷脂酰丝氨酸、N-乙酰神经氨酸、Y-氨基丁酸、蛋白酶、雨生红球藻、维生素C、L-赖氨酸、肽粉制备成食疗组方，该食疗组方为粉剂状的固体饮料，便于用户冲服；并且该食疗组方可以增强肌体免疫力，更有利于修复受损细胞，修复受损细胞的组合物促进胶原蛋白弹性纤维的形成，增强肌体免疫力，从而达到激活细胞能量、修复受损器官组织细胞、强化干细胞的功效，该食疗组方功能多样，能够科学平衡的对受损细胞进行修复，提高了受损细胞修复的效果。
具体实施方式
下面将对本发明实施例中的技术方案进行清楚、完整地描述，显然，所描述的实施例仅仅是本发明一部分实施例，而不是全部的实施例。基于本发明中的实施例，本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例，都属于本发明保护的范围。
实施例1
一种激活细胞能量、修复受损器官组织细胞、强化干细胞治疗潜能的食疗组方，所述食疗组方的各成分重量配比为：D-核糖15份、磷脂酰丝氨酸5份、N-乙酰神经氨酸5份、Y-氨基丁酸5份、蛋白酶1份、雨生红球藻15份、维生素C1份、L-赖氨酸5份、肽粉12份。
其中，肽粉的各成分重量配比为：牛心肽2份、牛肺肽2份、牛肝肽2份、牛脾肽2份、牛肾肽2份、牛脑肽2份。
其中，所述肽粉的制备方法包括以下步骤：
步骤一，按重量分别称取牛心肽、牛肺肽、牛肝肽、牛脾肽、牛肾肽、牛脑肽；
步骤二，然后依次将称取后的牛心肽、牛肺肽、牛肝肽、牛脾肽、牛肾肽、牛脑肽加入到反应釜中，通过反应釜混合均匀，然后出料，得到该肽粉。
一种激活细胞能量、修复受损器官组织细胞、强化干细胞治疗潜能的食疗组方的制备方法，包括以下步骤：
S101、按重量份分别称取D-核糖、磷脂酰丝氨酸、N-乙酰神经氨酸、Y-氨基丁酸、蛋白酶、雨生红球藻、维生素C、L-赖氨酸、肽粉，以备后续使用；
S102、先将D-核糖、磷脂酰丝氨酸、N-乙酰神经氨酸、Y-氨基丁酸和L-赖氨酸依次加入到反应釜内，通过反应釜搅拌10分钟，混合均匀，得到初始原料；
S103、然后将蛋白酶、雨生红球藻、维生素C和肽粉加入到反应釜中，通过反应釜继续搅拌10分钟，混合均匀，得到最终原料；
S104、将混合后的原料放入杀菌箱内，通过杀菌箱对混合原料进行杀菌处理，待杀菌结束后，进行封装处理，从而得到粉剂状的食疗组方。
实施例2
一种激活细胞能量、修复受损器官组织细胞、强化干细胞治疗潜能的食疗组方，所述食疗组方的各成分重量配比为：D-核糖20份、磷脂酰丝氨酸10份、N-乙酰神经氨酸10份、Y-氨基丁酸10份、蛋白酶3份、雨生红球藻20份、维生素C 3份、L-赖氨酸10份、肽粉18份。
其中，肽粉的各成分重量配比为：牛心肽3份、牛肺肽3份、牛肝肽3份、牛脾肽3份、牛肾肽3份、牛脑肽3份。
其中，所述肽粉的制备方法包括以下步骤：
步骤一，按重量分别称取牛心肽、牛肺肽、牛肝肽、牛脾肽、牛肾肽、牛脑肽；
步骤二，然后依次将称取后的牛心肽、牛肺肽、牛肝肽、牛脾肽、牛肾肽、牛脑肽加入到反应釜中，通过反应釜混合均匀，然后出料，得到该肽粉。
一种激活细胞能量、修复受损器官组织细胞、强化干细胞治疗潜能的食疗组方的制备方法，包括以下步骤：
S101、按重量份分别称取D-核糖、磷脂酰丝氨酸、N-乙酰神经氨酸、Y-氨基丁酸、蛋白酶、雨生红球藻、维生素C、L-赖氨酸、肽粉，以备后续使用；
S102、先将D-核糖、磷脂酰丝氨酸、N-乙酰神经氨酸、Y-氨基丁酸和L-赖氨酸依次加入到反应釜内，通过反应釜搅拌15分钟，混合均匀，得到初始原料；
S103、然后将蛋白酶、雨生红球藻、维生素C和肽粉加入到反应釜中，通过反应釜继续搅拌15分钟，混合均匀，得到最终原料；
S104、将混合后的原料放入杀菌箱内，通过杀菌箱对混合原料进行杀菌处理，待杀菌结束后，进行封装处理，从而得到粉剂状的食疗组方。
本发明的上述实施方式仅仅是为清楚地说明本发明所作的举例，而并非是对本发明的实施方式的限定。对于所属领域的普通技术人员来说，在上述说明的基础上还可以做出其它不同形式的变化或变动。这里无法对所有的实施方式予。以穷举。凡是属于本发明的技术方案所引伸出的显而易见的变化或变动仍处于本发明的保护范围之列。
Claims (7)
1.一种激活细胞能量、修复受损器官组织细胞、强化干细胞治疗潜能的食疗组方，其特征在于：所述食疗组方包括：D-核糖、磷脂酰丝氨酸、N-乙酰神经氨酸、Y-氨基丁酸、蛋白酶、雨生红球藻、维生素C、L-赖氨酸、肽粉。
2.根据权利要求1所述的一种激活细胞能量、修复受损器官组织细胞、强化干细胞治疗潜能的食疗组方，其特征在于，所述食疗组方的各成分重量配比为：D-核糖15-20份、磷脂酰丝氨酸5-10份、N-乙酰神经氨酸5-10份、Y-氨基丁酸5-10份、蛋白酶1-3份、雨生红球藻15-20份、维生素C1-3份、L-赖氨酸5-10份、肽粉12-18份。
3.根据权利要求1所述的一种激活细胞能量、修复受损器官组织细胞、强化干细胞治疗潜能的食疗组方，其特征在于，所述肽粉包括：牛心肽、牛肺肽、牛肝肽、牛脾肽、牛肾肽、牛脑肽。
4.根据权利要求3所述的一种激活细胞能量、修复受损器官组织细胞、强化干细胞治疗潜能的食疗组方，其特征在于，所述肽粉的各成分重量配比为：牛心肽2-3份、牛肺肽2-3份、牛肝肽2-3份、牛脾肽2-3份、牛肾肽2-3份、牛脑肽2-3份。
5.根据权利要求4所述的一种激活细胞能量、修复受损器官组织细胞、强化干细胞治疗潜能的食疗组方，其特征在于，所述牛心肽、牛肺肽、牛肝肽、牛脾肽、牛肾肽和牛脑肽的重量比为：1:1:1:1:1:1。
6.根据权利要求5所述的一种激活细胞能量、修复受损器官组织细胞、强化干细胞治疗潜能的食疗组方，其特征在于，所述肽粉的制备方法包括以下步骤：
步骤一，按重量分别称取牛心肽、牛肺肽、牛肝肽、牛脾肽、牛肾肽、牛脑肽；
步骤二，然后依次将称取后的牛心肽、牛肺肽、牛肝肽、牛脾肽、牛肾肽、牛脑肽加入到反应釜中，通过反应釜混合均匀，然后出料，得到该肽粉。
7.一种激活细胞能量、修复受损器官组织细胞、强化干细胞治疗潜能的食疗组方的制备方法，其特征在于，包括以下步骤：
S101、按重量份分别称取D-核糖、磷脂酰丝氨酸、N-乙酰神经氨酸、Y-氨基丁酸、蛋白酶、雨生红球藻、维生素C、L-赖氨酸、肽粉，以备后续使用；
S102、先将D-核糖、磷脂酰丝氨酸、N-乙酰神经氨酸、Y-氨基丁酸和L-赖氨酸依次加入到反应釜内，通过反应釜搅拌10-15分钟，混合均匀，得到初始原料；
S103、然后将蛋白酶、雨生红球藻、维生素C和肽粉加入到反应釜中，通过反应釜继续搅拌10-15分钟，混合均匀，得到最终原料；
S104、将混合后的原料放入杀菌箱内，通过杀菌箱对混合原料进行杀菌处理，待杀菌结束后，进行封装处理，从而得到粉剂状的食疗组方。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210212245.5A CN114521654A (zh) | 2022-03-04 | 2022-03-04 | 一种激活细胞能量、修复受损器官组织细胞、强化干细胞治疗潜能的食疗组方 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210212245.5A CN114521654A (zh) | 2022-03-04 | 2022-03-04 | 一种激活细胞能量、修复受损器官组织细胞、强化干细胞治疗潜能的食疗组方 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114521654A true CN114521654A (zh) | 2022-05-24 |
Family
ID=81626970
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210212245.5A Withdrawn CN114521654A (zh) | 2022-03-04 | 2022-03-04 | 一种激活细胞能量、修复受损器官组织细胞、强化干细胞治疗潜能的食疗组方 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114521654A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115624187A (zh) * | 2022-12-08 | 2023-01-20 | 北京第一生物科技开发有限公司 | 牛脾肽粉在改善睡眠中的用途 |
-
2022
- 2022-03-04 CN CN202210212245.5A patent/CN114521654A/zh not_active Withdrawn
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115624187A (zh) * | 2022-12-08 | 2023-01-20 | 北京第一生物科技开发有限公司 | 牛脾肽粉在改善睡眠中的用途 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108967800A (zh) | 一种功能性固体饮料及其制备方法 | |
| CN104336675A (zh) | 黑芝麻枸杞营养粥及制作方法 | |
| CN101243876A (zh) | 保健营养粉 | |
| WO2006070453A1 (ja) | 健康ドリンク | |
| CN110584101A (zh) | 爆珠燕窝、制备方法及饮品 | |
| CN113632851A (zh) | 一种多功能儿童生长奶粉及其制备方法 | |
| CN105918387A (zh) | 一种适用中老年保健食品及制备方法 | |
| CN114521654A (zh) | 一种激活细胞能量、修复受损器官组织细胞、强化干细胞治疗潜能的食疗组方 | |
| CN111374312A (zh) | 一种补充全面营养且易吸收的健康食品 | |
| CN105831658A (zh) | 一种绣球菌保健果冻 | |
| CN111480795A (zh) | 保健牛排及其制备方法 | |
| CN102018158A (zh) | 一种芦荟果酱 | |
| CN105212040A (zh) | 一种含黑玉米的复合营养粉及其制备方法 | |
| CN109123614A (zh) | 一种适合于航天员食用的黑色营养餐制剂 | |
| CN110651996A (zh) | 一种养护改善肾功能的食品及其制备方法 | |
| KR102131341B1 (ko) | 탈모 예방, 발모 촉진, 및 두피 개선 효과가 우수한 건강 선식 제조 방법 | |
| CN106070808A (zh) | 一种复合饮料及制作方法 | |
| RU2445797C1 (ru) | Продукт диетического, профилактического и функционального питания для спортивного питания | |
| CN113349380A (zh) | 一种含牡蛎复合肽肾功能改善剂及其制备方法 | |
| CN112137099A (zh) | 一种多功能营养食品配方 | |
| CN109527450A (zh) | 一种预防衰老壮阳补肾的组合物及其制备方法 | |
| CN108669434A (zh) | 妇女补虚养颜浆及加工方法 | |
| CN108783354A (zh) | 一种薏仁美容养生汤及其制备方法 | |
| CN101966263A (zh) | Ｓｏｄ抗氧化保健品 | |
| CN111838549A (zh) | 米胚膳食纤维粉的生产方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20220524 |
|
| WW01 | Invention patent application withdrawn after publication |